Prescribing patterns and drug-related problems (DRPs) in transfusion-dependent paediatric thalassemia patients: A prospective interventional study from a tertiary care hospital in India
- PMID: 33718575
- PMCID: PMC7922838
- DOI: 10.1016/j.ijpam.2020.01.001
Prescribing patterns and drug-related problems (DRPs) in transfusion-dependent paediatric thalassemia patients: A prospective interventional study from a tertiary care hospital in India
Abstract
Background: Each year nearly 10,000 children with thalassaemia major are born in India, but among them, very few are optimally managed mainly in urban regions even though the Government of India has incorporated their care and treatment in the 12th Five-Year Plan. Data on prescribing patterns and drug-related problems (DRPs) in paediatric thalassaemia patients in India are limited.
Methods: In this prospective interventional study, the medications prescribed were recorded after reviewing the treatment charts, thalassaemia register, thalassaemia card, nurses' notes, as well as discharge summaries. When DRPs and/or medication errors were identified, the same was discussed with the concerned health care professionals and suitable suggestions were made at the earliest.
Results: Out of the enrolled 54 patients, only 94% (n = 51) of the patients received iron chelation therapy with deferasirox and/or deferiprone, Folic acid tablet was prescribed for 100% of the patients (n = 54). Five percent of patients (n = 3) had undergone splenectomy and was prescribed with amoxicillin prophylactically. There were a total of 16 DRPs and 15 medication errors were identified and suitable measurements were taken to solve these problems.
Conclusions: The prescribing patterns, DRPs and medication errors in transfusion-dependent paediatric thalassaemia patients were discussed in this study. Our study was effective in identifying and solving the DRPs and medication problems that occurred in thalassaemia patients.
Keywords: Drug related problems; Medication errors; Paediatric patients; Prescribing patterns; Transfusion dependent thalassemia patients.
© 2020 Publishing services provided by Elsevier B.V. on behalf of King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia.
Conflict of interest statement
No financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.
Similar articles
-
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.Lancet Haematol. 2020 Jun;7(6):e469-e478. doi: 10.1016/S2352-3026(20)30100-9. Lancet Haematol. 2020. PMID: 32470438 Clinical Trial.
-
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study.Int J Clin Pharm. 2024 Jun;46(3):736-744. doi: 10.1007/s11096-024-01716-y. Epub 2024 Mar 29. Int J Clin Pharm. 2024. PMID: 38551751
-
Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major.Ann Trop Paediatr. 2011;31(1):47-51. doi: 10.1179/1465328110Y.0000000002. Ann Trop Paediatr. 2011. PMID: 21262109
-
Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes.Eur J Haematol. 2018 Sep;101(3):272-282. doi: 10.1111/ejh.13111. Epub 2018 Jul 27. Eur J Haematol. 2018. PMID: 29904950 Review.
-
Past, present & future scenario of thalassaemic care & control in India.Indian J Med Res. 2011 Oct;134(4):507-21. Indian J Med Res. 2011. PMID: 22089615 Free PMC article. Review.
Cited by
-
Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study.Front Pharmacol. 2023 Apr 20;14:1128887. doi: 10.3389/fphar.2023.1128887. eCollection 2023. Front Pharmacol. 2023. PMID: 37153805 Free PMC article.
References
-
- Muncie J.H., Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339–344. - PubMed
-
- Taher A.T., Cappellini M.D. How I manage medical complications of β-thalassemia in adults. Blood. 2018;132(17):1781–1791. - PubMed
-
- Porter J., Viprakasit V., Kattamis A. third ed. Thalassaemia International Federation; 2014. Iron overload and chelation. In guidelines for the management of transfusion dependent thalassaemia (TDT)[Internet] - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources